Aytu Biopharma (AYTU) Short term Debt (2011 - 2026)
Aytu Biopharma (AYTU) reported Short term Debt of $10.4 million for Q1 2026, up 460.64% year-over-year from $1.9 million in Q1 2025, and up 460.64% quarter-over-quarter from $1.9 million in Q4 2025.
Aytu Biopharma (AYTU) Short term Debt (2011 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 15 years of Short term Debt data on file, last reported at $10.4 million in Q1 2026.
- Short term Debt for Q1 2026 came in at $10.4 million, up 460.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.4 million (up 460.64% YoY), and the FY2025 annual result was $1.9 million, changed 0.0% from the prior year.
- Short term Debt climbed to $10.4 million in Q1 2026 per AYTU's latest filing, from $1.9 million in the prior quarter.
- Over five years, Short term Debt peaked at $14.9 million in Q3 2025 and troughed at $62000.0 in Q3 2023.
- A 5-year average of $3.5 million and a median of $1.9 million in 2024 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2023 and 2024: Short term Debt tumbled 93.3% in 2023, then jumped 2895.16% in 2024.
- A 5-year view of Short term Debt shows it stood at $90000.0 in 2022, then jumped by 1040.0% to $1.0 million in 2023, then jumped by 80.99% to $1.9 million in 2024, then changed by 0.0% to $1.9 million in 2025, then soared by 460.64% to $10.4 million in 2026.
- Business Quant data shows AYTU's Short term Debt at $10.4 million in Q1 2026, $1.9 million in Q4 2025, and $14.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.41 Mn |
| Dec 31, 2025 | 1.86 Mn |
| Sep 30, 2025 | 14.87 Mn |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 1.86 Mn |
| Mar 31, 2024 | 1.58 Mn |
| Dec 31, 2023 | 1.03 Mn |
| Sep 30, 2023 | 62,000.00 |
| Jun 30, 2023 | 1.56 Mn |
| Mar 31, 2023 | 10.40 Mn |
| Dec 31, 2022 | 90,000.00 |
| Sep 30, 2022 | 925,000.00 |
| Jun 30, 2022 | 3.81 Mn |
| Mar 31, 2022 | 3.39 Mn |
| Dec 31, 2021 | 1.21 Mn |
| Sep 30, 2021 | 4.52 Mn |
| Jun 30, 2021 | 7.93 Mn |